Evidence map›Paper›PMID 36728505›Full record

ArticleJournal of chemical information and modeling2023

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.

Yan A Ivanenkov, Daniil Polykovskiy, Dmitry Bezrukov, Bogdan Zagribelnyy, Vladimir Aladinskiy, Petrina Kamya, Alex Aliper, Feng Ren, Alex Zhavoronkov

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Trial
  2. Review
  3. Target discovery and drug design in the era of artificial intelligence.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. AI-drivenPeerJ · 2026
    Article
  17. AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Review
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yan A IvanenkovInsilico Medicine Kong Kong Ltd., Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong.ORCID 0000-0002-8968-0879
Daniil PolykovskiyInsilico Medicine Canada Inc., 3710-1250 René-Lévesque Blvd W, Montreal, Quebec, H3B 4W8 Canada.ORCID 0000-0002-0899-8368
Dmitry BezrukovInsilico Medicine Kong Kong Ltd., Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong.
Bogdan ZagribelnyyInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, PO Box 145748, Abu Dhabi, UAE.
Vladimir AladinskiyInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, PO Box 145748, Abu Dhabi, UAE.
Petrina KamyaInsilico Medicine Canada Inc., 3710-1250 René-Lévesque Blvd W, Montreal, Quebec, H3B 4W8 Canada.
Alex AliperInsilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, PO Box 145748, Abu Dhabi, UAE.
Feng RenInsilico Medicine Shanghai Ltd., Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road, Pudong New District, Shanghai 201203, China.ORCID 0000-0001-9157-9182
Alex ZhavoronkovInsilico Medicine Kong Kong Ltd., Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong.ORCID 0000-0001-7067-8966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemistry42 is a software platform for

Indexed as

Artificial IntelligenceDrug DiscoveryDrug DesignSoftware

Identifiers

PMID36728505
PMCPMC9930109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.